Results 251 to 260 of about 57,330 (350)

Necrolytic Migratory Erythema as the First Manifestation of Functional Conversion in a Glucagonoma: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Necrolytic migratory erythema is a characteristic but often underrecognized manifestation of glucagonoma. Its timely identification can lead to early diagnosis and curative surgery of pancreatic neuroendocrine tumors that initially present as clinically silent lesions.
Matheus Felipe Ferreira Aguiar   +1 more
wiley   +1 more source

Patch testing in adverse drug reactions [PDF]

open access: yes, 2011
Bruynzeel, DP, Gonçalo, Margarida
core  

Transforming Pharmacovigilance With Pharmacogenomics: Toward Personalized Risk Management

open access: yesClinical Pharmacology &Therapeutics, Volume 118, Issue 6, Page 1286-1296, December 2025.
Pharmacovigilance is a critical component of medication safety. Despite rigorous evaluation of new drugs during clinical trials, some adverse effects might only be identified once pharmaceuticals are used by a larger population for a longer duration.
Claire Spahn   +8 more
wiley   +1 more source

Fluconazole Induced Fixed Drug Eruption: Report of Three Cases

open access: bronze, 2014
Anupam Das   +4 more
openalex   +1 more source

Odevixibat after liver transplant in patients with progressive familial intrahepatic cholestasis type 1: A case series

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 81, Issue 6, Page 1410-1421, December 2025.
Abstract Objectives Patients with progressive familial intrahepatic cholestasis type 1 (PFIC1) who have undergone liver transplantation (LT) may have unmet needs and impacts on daily life due to post‐LT complications, including diarrhea and hepatic steatosis.
Georg‐Friedrich Vogel   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy